Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,846.50p on 04-09-2026 at 18:35:08
Change -20.00p -1.07%
Buy 1,844.50p
Sell 1,844.00p
Last Trade: Sell 62.00 at 1,846.50p
Day's Volume: 3,782,286
Last Close: 1,846.50p
Open: 1,866.00p
ISIN: GB00BN7SWP63
Day's Range 1,835.50p - 1,869.00p
52wk Range: 1,445.50p - 2,282.00p
Market Capitalisation: £73.99b
VWAP: 1,848.44436p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 62 1,846.50p SI Trade
16:40:52 - 04-Sep-26
Sell* 10,796 1,846.50p Automatic Execution
16:35:26 - 04-Sep-26
Buy* 9,204 1,846.50p Automatic Execution
16:35:26 - 04-Sep-26
Buy* 3 1,846.50p SI Trade
16:35:03 - 04-Sep-26
Buy* 1,298 1,846.50p SI Trade
16:35:03 - 04-Sep-26
Buy* 22 1,846.50p SI Trade
16:35:03 - 04-Sep-26
Buy* 5,047 1,846.50p SI Trade
16:35:03 - 04-Sep-26
Buy* 164 1,846.50p SI Trade
16:35:03 - 04-Sep-26
Buy* 8 1,846.50p SI Trade
16:35:03 - 04-Sep-26
Buy* 315 1,846.50p SI Trade
16:35:03 - 04-Sep-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Sep 2026 (Fri) 1,866.00 1,869.00 1,835.50 1,846.50 3,782,286
3rd Sep 2026 (Thu) 1,871.00 1,911.00 1,858.50 1,866.50 4,089,291
2nd Sep 2026 (Wed) 1,874.00 1,889.50 1,851.00 1,861.50 4,977,182
1st Sep 2026 (Tue) 1,847.50 1,892.00 1,842.00 1,871.50 4,718,988
31st Aug 2026 (Mon) 1,853.50 1,853.50 1,853.50 1,853.50 0
28th Aug 2026 (Fri) 1,862.50 1,863.00 1,839.50 1,853.50 7,789,320
27th Aug 2026 (Thu) 1,890.00 1,902.00 1,852.00 1,852.00 3,594,159
26th Aug 2026 (Wed) 1,914.00 1,919.00 1,891.00 1,899.50 3,465,884
25th Aug 2026 (Tue) 1,900.50 1,912.00 1,868.50 1,905.50 4,599,109
24th Aug 2026 (Mon) 1,917.00 1,921.50 1,882.00 1,890.50 5,274,882
21st Aug 2026 (Fri) 1,899.00 1,919.00 1,875.50 1,918.50 4,819,444
20th Aug 2026 (Thu) 1,927.00 1,936.50 1,902.00 1,920.50 8,380,816
19th Aug 2026 (Wed) 1,890.00 1,932.50 1,873.00 1,916.00 4,489,776
18th Aug 2026 (Tue) 1,861.50 1,893.00 1,851.50 1,888.00 3,706,336
17th Aug 2026 (Mon) 1,829.00 1,859.00 1,829.00 1,851.50 3,968,556
14th Aug 2026 (Fri) 1,855.50 1,856.00 1,803.50 1,817.50 14,890,876
13th Aug 2026 (Thu) 1,848.00 1,861.00 1,841.50 1,856.50 3,942,926
12th Aug 2026 (Wed) 1,889.00 1,891.00 1,843.00 1,869.00 6,128,496
11th Aug 2026 (Tue) 1,926.00 1,948.50 1,894.00 1,896.00 4,542,799
10th Aug 2026 (Mon) 1,970.00 1,972.00 1,904.00 1,927.50 5,928,673
7th Aug 2026 (Fri) 1,931.00 1,970.50 1,931.00 1,960.50 4,447,376
6th Aug 2026 (Thu) 1,934.00 1,954.00 1,928.00 1,936.50 3,138,502
5th Aug 2026 (Wed) 1,922.00 1,964.50 1,913.00 1,915.50 8,739,080
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
1st Sep 2026 3:00 pm RNS Total Voting Rights
1st Sep 2026 7:00 am RNS mRNA flu vaccine candidate to advance to phase III
26th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
24th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
24th Aug 2026 7:02 am RNS First global approval for Hibsago in Japan
24th Aug 2026 7:00 am RNS US FDA to review Jemperli for rectal cancer
18th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
13th Aug 2026 3:33 pm RNS Director/PDMR Shareholding
11th Aug 2026 3:30 pm RNS Director/PDMR Shareholding
3rd Aug 2026 3:00 pm RNS Total Voting Rights
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET MIDDAY: FTSE 100 edges higher; oil rises above USD97

3rd Sep 2026 12:10

(Alliance News) - Stock prices in London were higher at midday on Thursday, as gains for telecom stocks helped the FTSE 100 edge into positive territory, while investors digested stronger UK services activity and rising inflationary pressures in Europe. Read More

WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit

3rd Sep 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830

3rd Sep 2026 10:22

(Alliance News) - Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an exclusive development licence agreement with a subsidiary of GSK PLC. Read More

LONDON BRIEFING: LondonMetric investments; Jet2 eyes Main Market move

3rd Sep 2026 07:56

(Alliance News) - M&G swings to a first-half pretax loss attributable to equity holders as short-term investment fluctuations weigh on statutory results, while LondonMetric Property announces GBP105 million of investment activity. Elsewhere, Jet2 says trading remains strong and announces plans to move from AIM to London's Main Market. Read More

GSK advances mRNA flu vaccine to phase 3 after positive results

1st Sep 2026 11:23

(Alliance News) - GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate showed positive results and that phase 3 trials will start this month. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,831.09
Change-0.43

Login to your account

Forgot Password?

Not Registered